# FDA Inspection 638921 - Biomat USA, Inc. - January 15, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/821084c7-beb0-4101-8721-a8656233b849
Source feed: FDA_Inspections

> FDA Inspection 638921 for Biomat USA, Inc. on January 15, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 638921
- Company Name: Biomat USA, Inc.
- Inspection Date: 2010-01-15
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1067687 - 2018-09-20](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/2cc260d9-58db-41b9-b99a-e3704f48cdf2)
- [FDA Inspection 770062 - 2012-02-02](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/2d8a1b7f-9581-4b30-ae78-e87a2f534d80)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/3dd483d8-6679-47b8-8210-1572dcbb55e4

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d